Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13195)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 21, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Knab LM, Grippo PJ, Bentrem DJ. Involvement of eicosanoids in the pathogenesis of pancreatic cancer: The roles of cyclooxygenase-2 and 5-lipoxygenase. World J Gastroenterol 2014; 20(31): 10729-10739 [PMID: 25152576 DOI: 10.3748/wjg.v20.i31.10729] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i31/10729.htm |
| Number | Citing Articles |
| 1 |
Gangappa Dharmapuri, Ravinder Doneti, Gundala Harold Philip, Arunasree M. Kalle. Celecoxib sensitizes imatinib-resistant K562 cells to imatinib by inhibiting MRP1–5, ABCA2 and ABCG2 transporters via Wnt and Ras signaling pathways. Leukemia Research 2015; 39(7): 696 doi: 10.1016/j.leukres.2015.02.013
|
| 2 |
Weiqin Lu, Aihemaitijiang Aihaiti, Paziliya Abudukeranmu, Yajun Liu, Huihui Gao. Arachidonic acid metabolism as a novel pathogenic factor in gastrointestinal cancers. Molecular and Cellular Biochemistry 2024; doi: 10.1007/s11010-024-05057-2
|
| 3 |
Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker, Kenneth V. Honn. Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?. Cancer and Metastasis Reviews 2017; 36(2): 305 doi: 10.1007/s10555-017-9683-z
|
| 4 |
Yi-Wen Meng, Jun-Yan Liu. Pathological and pharmacological functions of the metabolites of polyunsaturated fatty acids mediated by cyclooxygenases, lipoxygenases, and cytochrome P450s in cancers. Pharmacology & Therapeutics 2024; 256: 108612 doi: 10.1016/j.pharmthera.2024.108612
|
| 5 |
Anuar Salazar-Gómez, Julio C. Ontiveros-Rodríguez, Saudy S. Pablo-Pérez, M. Elena Vargas-Díaz, Leticia Garduño-Siciliano. The potential role of sesquiterpene lactones isolated from medicinal plants in the treatment of the metabolic syndrome – A review. South African Journal of Botany 2020; 135: 240 doi: 10.1016/j.sajb.2020.08.020
|
| 6 |
Xiangyang Zeng, Shuijing Yi. Cyclooxygenase Inhibitors in Epithelial Ovarian Cancer Treatment. International Journal of Gynecological Cancer 2018; 28(6): 1085 doi: 10.1097/IGC.0000000000001269
|
| 7 |
Nagendra Sastry Yarla, Olga Sukocheva, Ilaria Peluso, Swathi Putta, Pallaval Veera Bramhachari, Rajesh Yadala, Dinesh K. Tiwari, Srinivas Jagarlamudi, Luciana Scotti, Marcus T. Scotti, Marcella Reale, Mohammad Amjad Kamal, Ashraf Ghulam, Bechan Sharma, Madhukiran Parvathaneni, Chinthalapally V. Rao, Mastan Mannarapu, Anupam Bishayee. Role of Transcription Factors in Gastrointestinal Malignancies. 2017; : 403 doi: 10.1007/978-981-10-6728-0_30
|
| 8 |
Alice Domenichini, Aleksandra Adamska, Marco Falasca. ABC transporters as cancer drivers: Potential functions in cancer development. Biochimica et Biophysica Acta (BBA) - General Subjects 2019; 1863(1): 52 doi: 10.1016/j.bbagen.2018.09.019
|
| 9 |
Manoj Kumar, Sunil Kumar Dhatwalia, D. K. Dhawan. Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis. Tumor Biology 2016; 37(11): 14341 doi: 10.1007/s13277-016-5330-5
|
| 10 |
Yihao Yang, Ya Zhang, Xin Qu, Junfeng Xia, Dongqi Li, Xiaojuan Li, Yu Wang, Zewei He, Su Li, Yonghong Zhou, Lin Xie, Zuozhang Yang. Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq. Oncotarget 2016; 7(52): 87194 doi: 10.18632/oncotarget.13554
|
| 11 |
Richard E. Kast, Alex Alfieri, Hazem I. Assi, Terry C. Burns, Ashraf M. Elyamany, Maria Gonzalez-Cao, Georg Karpel-Massler, Christine Marosi, Michael E. Salacz, Iacopo Sardi, Pieter Van Vlierberghe, Mohamed S. Zaghloul, Marc-Eric Halatsch. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen. Cancers 2022; 14(10): 2563 doi: 10.3390/cancers14102563
|
| 12 |
Kaka Renaldi, Marcellus Simadibrata, Nur Rahadiani, Diah Rini Handjari, Alida Roswita Harahap, Kuntjoro Harimurti, Nasrul Zubir, Lianda Siregar, Imelda Maria Loho, Evlina Suzanna, Bonita Prawirodihardjo, Heriawaty Hidajat, Budi Widodo, Alphania Rahniayu, Renaningtyas Tambun, Andy William, Dadang Makmun. The Expressions of NF−κB, COX−2, Sp1, and c−Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient Survival. Pathophysiology 2023; 30(2): 92 doi: 10.3390/pathophysiology30020009
|
| 13 |
Chinthalapally V. Rao, Chao Xu, Mudassir Farooqui, Yuting Zhang, Adam S. Asch, Hiroshi Y. Yamada. Survival-Critical Genes Associated with Copy Number Alterations in Lung Adenocarcinoma. Cancers 2021; 13(11): 2586 doi: 10.3390/cancers13112586
|
| 14 |
Yinghan Chan, Hui Shan Liew, Lesley Jia Wei Pua, Laura Soon, Sin Wi Ng, Joycelin Zhu Xin Tan, Dinesh Kumar Chellappan, Kamal Dua. Recent Developments in Anti-Inflammatory Therapy. 2023; : 113 doi: 10.1016/B978-0-323-99988-5.00001-2
|
| 15 |
Altaf Mohammed, Naveena B. Janakiram, Venkateshwar Madka, Misty Brewer, Rebekah L. Ritchie, Stan Lightfoot, Gaurav Kumar, Michael Sadeghi, Jagan Mohan R. Patlolla, Hiroshi Y. Yamada, Zobeida Cruz-Monserrate, Randal May, Courtney W. Houchen, Vernon E. Steele, Chinthalapally V. Rao. Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression. Oncotarget 2015; 6(17): 15524 doi: 10.18632/oncotarget.3499
|
| 16 |
Xianping Huang, Weihe Zhou, Yuefeng Zhang, Yong Liu. High Expression of PTGR1 Promotes NSCLC Cell Growth via Positive Regulation of Cyclin-Dependent Protein Kinase Complex. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/5230642
|
| 17 |
Chaoqun Liu, Paul Chi-Lui Ho, Fang Cheng Wong, Gautam Sethi, Ling Zhi Wang, Boon Cher Goh. Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects. Cancer Letters 2015; 362(1): 8 doi: 10.1016/j.canlet.2015.03.019
|
| 18 |
Caixia Li, Rong Chen, Caixia Jiang, Li Chen, Zhongping Cheng. Correlation of LOX‑5 and COX‑2 expression with inflammatory pathology and clinical features of adenomyosis. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9618
|
| 19 |
Rui Liu, Kang-Ping Xu, Gui-Shan Tan. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed. European Journal of Pharmacology 2015; 769: 127 doi: 10.1016/j.ejphar.2015.11.007
|
| 20 |
Lavínia de C. Brito, Ana Luiza Rangel Berenger, Maria Raquel Figueiredo. An overview of anticancer activity of Garcinia and Hypericum. Food and Chemical Toxicology 2017; 109: 847 doi: 10.1016/j.fct.2017.03.053
|
| 21 |
Cándido Ortiz-Placín, Alba Castillejo-Rufo, Matías Estarás, Antonio González. Membrane Lipid Derivatives: Roles of Arachidonic Acid and Its Metabolites in Pancreatic Physiology and Pathophysiology. Molecules 2023; 28(11): 4316 doi: 10.3390/molecules28114316
|
| 22 |
Carolina Torres, Georgina Mancinelli, Jose Cordoba-Chacon, Navin Viswakarma, Karla Castellanos, Sam Grimaldo, Sandeep Kumar, Daniel Principe, Matthew J. Dorman, Ronald McKinney, Emilio Hirsch, David Dawson, Hidayatullah G. Munshi, Ajay Rana, Paul J. Grippo. p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity. Proceedings of the National Academy of Sciences 2019; 116(29): 14724 doi: 10.1073/pnas.1813012116
|
| 23 |
Suman Kumar Ray, Erukkambattu Jayashankar, Ashwin Kotnis, Sukhes Mukherjee. Oxidative versus Reductive Stress in Breast Cancer Development
and Cellular Mechanism of Alleviation: A Current Perspective with
Anti-breast Cancer Drug Resistance. Current Molecular Medicine 2024; 24(2): 205 doi: 10.2174/1566524023666230309112751
|
| 24 |
Ying Luo, Jun-Yan Liu. Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.580897
|
| 25 |
Lou Saier, Olivier Peyruchaud. Emerging role of cysteinyl LTs in cancer. British Journal of Pharmacology 2022; 179(22): 5036 doi: 10.1111/bph.15402
|
| 26 |
Samar Basu, Holly Harris, Alicja Wolk, Adrien Rossary, Florence Caldefie-Chézet, Marie-Paule Vasson, Anders Larsson. Inflammatory F2-isoprostane, prostaglandin F2α, pentraxin 3 levels and breast cancer risk: The Swedish Mammography Cohort. Prostaglandins, Leukotrienes and Essential Fatty Acids 2016; 113: 28 doi: 10.1016/j.plefa.2016.08.005
|
| 27 |
Terézia Kisková, Monika Kassayová. Resveratrol Action on Lipid Metabolism in Cancer. International Journal of Molecular Sciences 2019; 20(11): 2704 doi: 10.3390/ijms20112704
|
| 28 |
Alison L. Halpern, Patrick D. Kohtz, Jessica Y. Rove, Lihua Ao, Xianzhong Meng, David A. Fullerton, Michael J. Weyant. Inhibition of secretory phospholipase A2 IIa attenuates prostaglandin E2-induced invasiveness in lung adenocarcinoma. Molecular and Cellular Biochemistry 2019; 456(1-2): 145 doi: 10.1007/s11010-019-03500-3
|
| 29 |
Danilo Hackner, Mirianna Hobbs, Susanne Merkel, Christian Krautz, Georg F. Weber, Robert Grützmann, Maximilian Brunner. Impact of Aspirin Intake on Postoperative Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma—A Single-Center Evaluation. Biomedicines 2023; 11(5): 1466 doi: 10.3390/biomedicines11051466
|
| 30 |
Shanthi Nagarajan, Zu Yuan Qian, Parthiban Marimuthu, Nabil J. Alkayed, Sanjiv Kaul, Anthony P. Barnes. Mapping the Molecular Architecture Required for Lipid-Binding Pockets Using a Subset of Established and Orphan G-Protein Coupled Receptors. Journal of Chemical Information and Modeling 2021; 61(7): 3442 doi: 10.1021/acs.jcim.1c00335
|
| 31 |
Shuangyuan Wang, Mian Li, Li Yan, Meian He, Hong Lin, Yu Xu, Qin Wan, Guijun Qin, Gang Chen, Min Xu, Guixia Wang, Yingfen Qin, Zuojie Luo, Xulei Tang, Tiange Wang, Zhiyun Zhao, Yiping Xu, Yuhong Chen, Yanan Huo, Ruying Hu, Zhen Ye, Meng Dai, Lixin Shi, Zhengnan Gao, Qing Su, Yiming Mu, Jiajun Zhao, Lulu Chen, Tianshu Zeng, Xuefeng Yu, Qiang Li, Feixia Shen, Li Chen, Yinfei Zhang, Youmin Wang, Huacong Deng, Chao Liu, Shengli Wu, Tao Yang, Donghui Li, Guang Ning, Tangchun Wu, Weiqing Wang, Yufang Bi, Jieli Lu. Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer. International Journal of Cancer 2022; 150(7): 1091 doi: 10.1002/ijc.33877
|
| 32 |
Sara Busechian, Rodolfo Gialletti, Chiara Brachelente, Jacopo Corsalini, Sara Nannarone, Fabrizio Rueca. Transitional Cell Carcinoma of the Bladder in a 12-Year-Old Gelding. Journal of Equine Veterinary Science 2016; 40: 80 doi: 10.1016/j.jevs.2016.02.226
|
| 33 |
Aleksandra Adamska, Marco Falasca. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?. World Journal of Gastroenterology 2018; 24(29): 3222-3238 doi: 10.3748/wjg.v24.i29.3222
|
| 34 |
Samuel S. Linton, Thomas Abraham, Jason Liao, Gary A. Clawson, Peter J. Butler, Todd Fox, Mark Kester, Gail L. Matters, Aamir Ahmad. Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. PLOS ONE 2018; 13(11): e0206759 doi: 10.1371/journal.pone.0206759
|
| 35 |
Reinhard Waehler. Fatty acids: facts vs. fiction. International Journal for Vitamin and Nutrition Research 2023; 93(3): 268 doi: 10.1024/0300-9831/a000713
|
| 36 |
Mohammad Mazharul Islam, Andrea Goertzen, Pankaj K. Singh, Rajib Saha. Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modeling. iScience 2022; 25(6): 104483 doi: 10.1016/j.isci.2022.104483
|
| 37 |
Xīn Gào, Ben Schöttker. Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews. Oncotarget 2017; 8(31): 51888 doi: 10.18632/oncotarget.17128
|
| 38 |
Wojciech Blogowski, Katarzyna Dolegowska, Anna Deskur, Barbara Dolegowska, Teresa Starzynska. Lipoxins and Resolvins in Patients With Pancreatic Cancer: A Preliminary Report. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.757073
|
| 39 |
Huimin Huang, Shipeng Zhou, Xingling Zhao, Shitong Wang, Huajun Yu, Linhua Lan, Liyi Li. Construction of a metabolism-related gene prognostic model to predict survival of pancreatic cancer patients. Heliyon 2023; 9(1): e12378 doi: 10.1016/j.heliyon.2022.e12378
|
| 40 |
Xingfu Wang, Yupeng Chen, Sheng Zhang, Lifeng Zhang, Xueyong Liu, Li Zhang, Xiaoling Li, Dayang Chen. Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis. Journal of Neuro-Oncology 2015; 125(2): 277 doi: 10.1007/s11060-015-1919-6
|
| 41 |
Alessandra Pannunzio, Mauro Coluccia. Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature. Pharmaceuticals 2018; 11(4): 101 doi: 10.3390/ph11040101
|
| 42 |
Shayeri Chatterjee Ganguly, Beduin Mahanti, Soumya Ganguly, Subhabrota Majumdar. Bovine serum albumin as a nanocarrier for efficient encapsulation of hydrophobic garcinol-A strategy for modifying the in vitro drug release kinetics. International Journal of Biological Macromolecules 2024; 278: 134651 doi: 10.1016/j.ijbiomac.2024.134651
|
| 43 |
Gillian Moore, Graham Pidgeon. Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway. International Journal of Molecular Sciences 2017; 18(2): 236 doi: 10.3390/ijms18020236
|
| 44 |
Silvia Zappavigna, Alessia Maria Cossu, Anna Grimaldi, Marco Bocchetti, Giuseppe Andrea Ferraro, Giovanni Francesco Nicoletti, Rosanna Filosa, Michele Caraglia. Anti-Inflammatory Drugs as Anticancer Agents. International Journal of Molecular Sciences 2020; 21(7): 2605 doi: 10.3390/ijms21072605
|
| 45 |
Kazuki Moro, Masayuki Nagahashi, Rajesh Ramanathan, Kazuaki Takabe, Toshifumi Wakai. Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer. World Journal of Clinical Cases 2016; 4(7): 155-164 doi: 10.12998/wjcc.v4.i7.155
|
| 46 |
Niraldo Paulino, Amarilis Scremin Paulino, Susana N. Diniz, Sergio de Mendonça, Ivair D. Gonçalves, Fernanda Faião Flores, Reginaldo Pereira Santos, Carina Rodrigues, Paulo Celso Pardi, José Agustin Quincoces Suarez. Evaluation of the anti-inflammatory action of curcumin analog (DM1): Effect on iNOS and COX-2 gene expression and autophagy pathways. Bioorganic & Medicinal Chemistry 2016; 24(8): 1927 doi: 10.1016/j.bmc.2016.03.024
|
| 47 |
Jihua Zhang, Luying Shi, Jingya Duan, Minmin Li, Canyu Li. Proteomic detection of COX-2 pathway-related factors in patients with adenomyosis. PeerJ 2024; 12: e16784 doi: 10.7717/peerj.16784
|
| 48 |
Mingfeng Zhang, Soren Lykke-Andersen, Bin Zhu, Wenming Xiao, Jason W Hoskins, Xijun Zhang, Lauren M Rost, Irene Collins, Martijn van de Bunt, Jinping Jia, Hemang Parikh, Tongwu Zhang, Lei Song, Ashley Jermusyk, Charles C Chung, Bin Zhu, Weiyin Zhou, Gail L Matters, Robert C Kurtz, Meredith Yeager, Torben Heick Jensen, Kevin M Brown, Halit Ongen, William R Bamlet, Bradley A Murray, Mark I McCarthy, Stephen J Chanock, Nilanjan Chatterjee, Brian M Wolpin, Jill P Smith, Sara H Olson, Gloria M Petersen, Jianxin Shi, Laufey Amundadottir. Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues. Gut 2018; 67(3): 521 doi: 10.1136/gutjnl-2016-313146
|
| 49 |
Alessio Cimmino, Pier Luigi Nimis, Marco Masi, Laura De Gara, Willem A. L. van Otterlo, Robert Kiss, Antonio Evidente, Florence Lefranc. Have lichenized fungi delivered promising anticancer small molecules?. Phytochemistry Reviews 2019; 18(1): 1 doi: 10.1007/s11101-018-9577-x
|
| 50 |
S Beloribi-Djefaflia, S Vasseur, F Guillaumond. Lipid metabolic reprogramming in cancer cells. Oncogenesis 2016; 5(1): e189 doi: 10.1038/oncsis.2015.49
|
| 51 |
Maria Karmella Apaya, Meng-Ting Chang, Lie-Fen Shyur. Phytomedicine polypharmacology: Cancer therapy through modulating the tumor microenvironment and oxylipin dynamics. Pharmacology & Therapeutics 2016; 162: 58 doi: 10.1016/j.pharmthera.2016.03.001
|